InCytu, Inc. is therapeutic device engineering company developing immunotherapeutic and tissue regeneration products that transform personalized medicine.

Capable of harnessing and amplifying the body’s natural processes, InCytu’s breakthrough Cellarium™ platform technology was first developed in Professor David Mooney’s lab at Harvard University. Cellarium’s  intelligent biopolymer system is placed in situ to attract, educate, manipulate and locally re-deliver specific, functionally optimized and physiologically correct cells.

Driven by a seasoned senior management team with extensive experience in the commercialization of revolutionary therapies and regenerative medicines, InCytu is developing simple, yet elegant products to bring this transformative technology to under-served patient populations.

InCytu plays an important role in the future of personalized medicine.  Learn more about InCytu or contact us for more information.

© 2009 InCytu Incorporated